• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Abbott’s sales increased 4% in Q2, slight revisions made to guidance

cafead

Administrator
Staff member
  • cafead   Jul 18, 2024 at 11:02: PM
via Abbott Laboratories reported a 4% increase in quarterly sales, totalling $10.4 billion.

The company released its latest earnings report Thursday and subsequently revised its full-year financial guidance.

article source
 

<